Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients-Reference-Cited by-同舟云学术

Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients

Published:2013-04-29 Issue:4 Volume:8 Page:e62540
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

López-Gómez Carlos,Pino-Ángeles Almudena,Órpez-Zafra Teresa,Pinto-Medel María Jesús,Oliver-Martos Begoña,Ortega-Pinazo Jesús,Arnáiz Carlos,Guijarro-Castro Cristina,Varadé Jezabel,Álvarez-Lafuente Roberto,Urcelay Elena,Sánchez-Jiménez Francisca,Fernández Óscar,Leyva Laura

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Interferon-beta-1b: in newly emerging multiple sclerosis;K McKeage;CNS Drugs,2008

2. Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group;SA Doggrell;Expert Opin Pharmacother,2010

3. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis;Lancet,1998

4. Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study;O Fernandez;Acta Neurol Scand,2003

5. Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients;J Rio;Ann Neurol,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From periphery to center stage: 50 years of advancements in innate immunity;Cell;2024-04

2. Selection and validation of reference genes for qRT-PCR in cultivated octoploid strawberry;Fruit Research;2024

3. Literatur;Multiple Sklerose;2022

4. Pharmacogenetic Predictors of Response to Interferon Beta Therapy in Multiple Sclerosis;Molecular Neurobiology;2021-06-24

5. An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis;Journal of Neuroimmunology;2021-04